117248-94-9

Upstream product

• 85846-80-6 5-O-benzyl-2,3-O-isopropylidene-D-ribono-1,4-lactone 
• 212003-35-5 allyl 5-O-benzyl-2,3-O-isopropylidene-β-D-ribofuranoside 
• 126862-99-5 (6-allyloxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol 
• 100-39-0 benzyl bromide 
• 532-20-7 D-Ribose 
• 198969-39-0 5-O-benzyl-2,3-O-isopropylidene-D-ribofuranose 
• 5336-08-3 D-Ribono-1,4-lactone 
• 30725-00-9 2,3-O-isopropylidene-D-ribonic-γ-lactone 

Downstream Products

• 117174-48-8 2-Benzyloxy-1-[(4R,5S)-5-(tert-butyl-diphenyl-silanyloxymethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-ethanol 
• 117174-51-3 [(4S,5R)-5-(2-Benzyloxy-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-methanol 
• 117174-52-4 Methanesulfonic acid (2S,3R)-5-benzyloxy-2,3-dihydroxy-pentyl ester 
• 117192-24-2 Methanesulfonic acid (4S,5R)-5-(2-benzyloxy-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester 
• 117174-53-5 (2S,3R)-1-(6-Amino-purin-9-yl)-5-benzyloxy-pentane-2,3-diol 
• 117174-54-6 (2S,3R)-1-(6-Amino-purin-3-yl)-5-benzyloxy-pentane-2,3-diol 
• 117174-50-2 [(4S,5R)-5-(2-Benzyloxy-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy]-tert-butyl-diphenyl-silane 
• 117174-49-9 Dithiocarbonic acid O-{2-benzyloxy-1-[(4S,5S)-5-(tert-butyl-diphenyl-silanyloxymethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-ethyl} ester S-methyl ester 
• 117174-48-8 1-O-tert-butyldiphenylsilyl-5-O-benzyl-2,3-O-isopropylidene-D-ribitol 
• 130114-57-7 (2S,3R)-5-benzyl-2,3-O-isopropylidene-4-C-methylene-D-erytho-pentitol 
• 495397-67-6 (4R,5R)-5-(1-Benzyloxymethyl-vinyl)-2,2-dimethyl-[1,3]dioxolane-4-carbaldehyde 
• 848862-73-7 1-O-tert-butyldiphenylsilyl-5-O-benzyl-2,3-O-isopropylidene-4-keto-D-erythro-pentitol 
• 848862-75-9 1-O-tert-butyldiphenylsilyl-5-O-benzyl-2,3-O-isopropylidene-4-C-methylene-D-erythro-pentitol 
• 13046-77-0 5-benzyloxy-D-ribitol 

Relevant academic research and scientific papers

Ophthamological drugs

The present invention relates generally to ophthamological drugs. More specifically, the inventon relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to d

Synthetic studies toward the preparation of (4R,5R)-(-)-3-[(benzyloxy) methyl]-4,5-O-isopropylidene-cyclopenten-2-one: An important synthetic intermediate for carbanucleosides

The carbocyclic compound (4R,5R)-(-)-3-[(benzyloxy)methyl]-4,5-O- isopropylidene-2-cyclopentenone 1 is an important synthetic intermediate to access a variety of carbanucleosides. Herein, synthetic studies that lead to this valuable compound employing ine